[Clinical and immunological bases of effectiveness of the use of endolymphatic therapy in the treatment of patients with pleural empyema].
Feshchenko
Iu I
IuI
Pristaĭko
Ia I
IaI
Opanasenko
N S
NS
Fedoruk
N I
NI
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001402:B-Lymphocytes / Q000276:immunology; D016724:Empyema, Pleural / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D006801:Humans; D007272:Injections, Intralymphatic; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D010587:Phagocytosis; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000276:immunology
D000900:Anti-Bacterial Agents